Endoh M - Search Results

1

Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart.

Hino M, Sugawara H, Yoshimura A, Ogura A, Yoshioka K, Sakato M, Endoh M. Hino M, et al. Among authors: endoh m. Arzneimittelforschung. 1999 May;49(5):398-406. doi: 10.1055/s-0031-1300434. Arzneimittelforschung. 1999. PMID: 10367101

2

A novel cardiotonic agent SCH00013 acts as a Ca++ sensitizer with no chronotropic activity in mammalian cardiac muscle.

Sugawara H, Endoh M. Sugawara H, et al. Among authors: endoh m. J Pharmacol Exp Ther. 1998 Oct;287(1):214-22. J Pharmacol Exp Ther. 1998. PMID: 9765340

3

Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 2nd communication: in vivo cardiovascular effects and bioavailability in dogs.

Yoshimura A, Koide Y, Yoshioka K, Hino M, Sugawara H, Sakato M, Endoh M. Yoshimura A, et al. Among authors: endoh m. Arzneimittelforschung. 1999 May;49(5):407-11. doi: 10.1055/s-0031-1300435. Arzneimittelforschung. 1999. PMID: 10367102

4

Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 3rd communication: stereoselectivity of the enantiomers in cardiovascular effects.

Sugawara H, Hino M, Yoshimura A, Yoshioka K, Sakato M, Endoh M. Sugawara H, et al. Among authors: endoh m. Arzneimittelforschung. 1999 May;49(5):412-9. doi: 10.1055/s-0031-1300436. Arzneimittelforschung. 1999. PMID: 10367103

5

Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 4th communication: influence on experimentally induced ventricular arrhythmia in dogs.

Yoshimura A, Yoshioka K, Hino M, Sugawara H, Sakato M, Endoh M. Yoshimura A, et al. Among authors: endoh m. Arzneimittelforschung. 1999 May;49(5):420-6. doi: 10.1055/s-0031-1300437. Arzneimittelforschung. 1999. PMID: 10367104

6

(-)-Enantiomer EMD 57439 antagonizes the Ca2+ sensitizing effect of (+)-enantiomer EMD 57033 on diastolic function but not on systolic function in rabbit ventricular cardiomyocytes.

Sugawara H, Endoh M. Sugawara H, et al. Among authors: endoh m. Jpn J Pharmacol. 1999 May;80(1):55-65. doi: 10.1254/jjp.80.55. Jpn J Pharmacol. 1999. PMID: 10446757 Free article.

7

Pharmacology of SCH00013: a novel Ca2+ sensitizer.

Endoh M, Sugawara H, Mineshima M. Endoh M, et al. Cardiovasc Drug Rev. 2001 Winter;19(4):345-66. doi: 10.1111/j.1527-3466.2001.tb00075.x. Cardiovasc Drug Rev. 2001. PMID: 11830752 Review.

8

Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.

Sato S, Talukder MA, Sugawara H, Sawada H, Endoh M. Sato S, et al. Among authors: endoh m. J Mol Cell Cardiol. 1998 Jun;30(6):1115-28. doi: 10.1006/jmcc.1998.0677. J Mol Cell Cardiol. 1998. PMID: 9689586

9

Role of Na+/Ca2+ exchange in endothelin-1-induced increases in Ca2+ transient and contractility in rabbit ventricular myocytes: pharmacological analysis with KB-R7943.

Yang HT, Sakurai K, Sugawara H, Watanabe T, Norota I, Endoh M. Yang HT, et al. Among authors: endoh m. Br J Pharmacol. 1999 Apr;126(8):1785-95. doi: 10.1038/sj.bjp.0702454. Br J Pharmacol. 1999. PMID: 10372821 Free PMC article.

10

Differential alteration of cardiotonic effects of EMD 57033 and beta-adrenoceptor agonists in volume-overload rabbit ventricular myocytes.

Sugawara H, Sakurai K, Atsumi H, Nakada S, Tomoike H, Endoh M. Sugawara H, et al. Among authors: endoh m. J Card Fail. 2000 Dec;6(4):338-49. doi: 10.1054/jcaf.2000.19237. J Card Fail. 2000. PMID: 11145759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

789 results

Search Page

Filters